A. Azzarello

Novo Nordisk (Denmark)

Papers

1

Total Citations

52

H-Index

1

About

Driven by a vision to transform drug delivery, A. Azzarello pioneers bioinspired robotic systems that navigate the body’s most challenging environments. Their core research lies at the intersection of soft robotics, biomimicry, and gastrointestinal medicine, with a particular focus on developing ingestible devices that replace painful injections. Azzarello’s landmark 2024 paper, “Cephalopod-inspired jetting devices for gastrointestinal drug delivery,” has already garnered 52 citations, reflecting its immediate impact. This work introduces a novel, needle-free platform that mimics the jet-propulsion mechanisms of cephalopods, enabling the precise, high-velocity delivery of biomacromolecule therapies—such as insulin or monoclonal antibodies—directly through the gastrointestinal lining. By eliminating the need for sharps, specialized training, and disposal protocols, this innovation promises to make life-saving treatments more accessible and patient-friendly. Azzarello’s contributions are reshaping how we think about oral biologics, offering a tangible path toward painless, autonomous drug administration. Their work not only advances soft robotics but also bridges engineering with clinical need, positioning them as a rising leader in the field of ingestible medical devices.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Cephalopod-inspired jetting devices for gastrointestinal drug delivery
52 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Novo Nordisk (Denmark)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago